Tiziana Pivetta

Prof. Dr. Tiziana Pivetta

Dipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cagliari, Italy
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Journal of Applied Biomedicine
Verified
Journal Article
Closed access
FTFederica Trudu
Federica Trudu
FAFilippo Amato
Filippo Amato
PVPetr Vaňhara
Petr Vaňhara
TPTiziana Pivetta
Tiziana Pivetta
Eladia M Peña-MéndezEladia M Peña-Méndez
Eladia M Peña-Méndez
JHJosef Havel
Josef Havel

1 April 2008 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Valeria Marina NurchiValeria Marina Nurchi
Valeria Marina Nurchi
Guido CrisponiGuido Crisponi
Guido Crisponi
TPTiziana Pivetta
Tiziana Pivetta
MDMartina Donatoni
Martina Donatoni
MRMaurizio Remelli
Maurizio Remelli

1 February 2009 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Valeria Marina NurchiValeria Marina Nurchi
Valeria Marina Nurchi
TPTiziana Pivetta
Tiziana Pivetta
JLJoanna Izabela Lachowicz
Joanna Izabela Lachowicz
Guido CrisponiGuido Crisponi
Guido Crisponi

22 December 2021 in Molecules
Verified
Journal Article
Open access
PDF file
SMSebastiano Masuri
Sebastiano Masuri
PVPetr Vanhara
Petr Vanhara
MCMaria Grazia Cabiddu
Maria Grazia Cabiddu
LMLukáš Moráň
Lukáš Moráň
JHJosef Havel
Josef Havel
TPTiziana Pivetta
Tiziana Pivetta
Copper is an endogenous metal ion that has been studied to prepare a new antitumoral agent with less side-effects. Copper is involved as a cofactor in several enzymes, in ROS production, in the promotion of tumor progression, metastasis, and angiogenesis, and has been found at high levels in serum and tissues of several types of human cancers. Under these circumstances, two strategies are commonly followed in the development of novel anticancer Copper-based drugs: the sequestration of free Copper ions and the synthesis of Copper complexes that trigger cell death. The latter strategy has been followed in the last 40 years and many reviews have covered the anticancer properties of a broad spectrum of Copper complexes, showing that the activity of these compounds is often multi factored. In this work, we would like to focus on the anticancer properties of mixed Cu(II) complexes bearing substituted or unsubstituted 1,10-phenanthroline based ligands and different classes of inorganic and organic auxiliary ligands. For each metal complex, information regarding the tested cell lines and the mechanistic studies will be reported and discussed. The exerted action mechanisms were presented according to the auxiliary ligand/s, the metallic centers, and the increasing complexity of the compound structures.

1 May 2010 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
Valeria Marina NurchiValeria Marina Nurchi
Valeria Marina Nurchi
Guido CrisponiGuido Crisponi
Guido Crisponi
JLJoanna Izabela Lachowicz
Joanna Izabela Lachowicz
SMSergio Murgia
Sergio Murgia
TPTiziana Pivetta
Tiziana Pivetta
Zbigniew SzewczukZbigniew Szewczuk
Zbigniew Szewczuk

20 December 2005 in Inorganic Chemistry
Verified
Journal Article
Closed access
JGJosefa Gonzalez-Perez
Josefa Gonzalez-Perez
CACarolina Alarcón-Payer
Carolina Alarcón-Payer
ACAlfonso Castiñeiras Campos
Alfonso Castiñeiras Campos
TPTiziana Pivetta
Tiziana Pivetta
LLLuis Lezama
Luis Lezama
JNJuan Niclós-Gutiérrez
Juan Niclós-Gutiérrez